DrugInfoSys

Drotaverine

Drug #895

Drotaverine is Cholinergic muscarinic antagonist. Drotaverine is used in smooth muscle spasm and stone formation.

Primary Characteristics

Drotaverine is also known as Drotaverine Hcl.

It belongs to Papavecine.

It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Antispasmodic Agent pharmacological group.

Molecular Weight: 397.5 · Solubility in Water: null · Solubility in Alcohol: null · Non-proprietary name: Drotaverine.

Molecular structure of Drotaverine

Pharmacokinetics

None recorded.

Advertisement

Indications

Contraindications

Dosage

Drotaverine's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
50 mg50 mgEvery 8hIV,IM
120 – 240 mgEvery 3hPO
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

Unknown1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Drotaverine in overdosage may give rise to further complications which include Porphyria.

Drotaverine is known to cause more or less tolerable side effects which are usually transient. These include Constipation , Dizziness, Dry mouth, Headache, Hypotension , Insomnia, Nausea, Palpitation, Vertigo, Vomiting .

Warnings / Precautions

Fusidic acid is metabilized by the liver and excreted mainly through the bile, periodic liver function test should be carried out in the patient with liver dysfunction abnormalities in the biliary pathway or when the fusidic acid is given for prolonged periods, or when it is given in combination with other antibiotics which have similar excretion pathways, e.g. lincomycin and rifampicin.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Drotaverine should be stored .

Drug Classification

  1. 1.17.5Antispasmodics

Manufacturers